These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1685644)

  • 1. Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease-associated protein.
    Nemeroff CB; Bissette G; Slotkin TA; Seidler FJ; Miller BE; Ghanbari H
    Ann N Y Acad Sci; 1991; 640():193-6. PubMed ID: 1685644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptides in Alzheimer's disease: a postmortem study.
    Nemeroff CB; Kizer JS; Reynolds GP; Bissette G
    Regul Pept; 1989 Apr; 25(1):123-30. PubMed ID: 2566190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides in the neocortex in Alzheimer's disease and ageing.
    Ferrier IN; Leake A
    Psychoneuroendocrinology; 1990; 15(2):89-95. PubMed ID: 1972799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease.
    Horgan J; Miguel-Hidalgo JJ; Thrasher M; Bissette G
    J Alzheimers Dis; 2007 Sep; 12(2):115-27. PubMed ID: 17917156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses.
    Justice NJ; Huang L; Tian JB; Cole A; Pruski M; Hunt AJ; Flores R; Zhu MX; Arenkiel BR; Zheng H
    J Neurosci; 2015 Feb; 35(6):2612-23. PubMed ID: 25673853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer's disease-related signaling.
    Bangasser DA; Dong H; Carroll J; Plona Z; Ding H; Rodriguez L; McKennan C; Csernansky JG; Seeholzer SH; Valentino RJ
    Mol Psychiatry; 2017 Aug; 22(8):1126-1133. PubMed ID: 27752081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.
    De Souza EB; Whitehouse PJ; Kuhar MJ; Price DL; Vale WW
    Nature; 1986 Feb 13-19; 319(6054):593-5. PubMed ID: 3003585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [beta-Amyloid, cholinergic neurons and Alzheimer's disease].
    Kasparová J; Dolezal V
    Cesk Fysiol; 2002 May; 51(2):82-94. PubMed ID: 12053492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in Alzheimer's disease and control postmortem human brain.
    Behan DP; Khongsaly O; Owens MJ; Chung HD; Nemeroff CB; De Souza EB
    J Neurochem; 1997 May; 68(5):2053-60. PubMed ID: 9109532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuropeptides in Alzheimer's disease].
    Jiménez-Corral C; Morán-Sánchez JC; Alonso-Navarro H
    Rev Neurol; 2006 Mar 16-31; 42(6):354-9. PubMed ID: 16575772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin and Alzheimer's disease.
    Burgos-Ramos E; Hervás-Aguilar A; Aguado-Llera D; Puebla-Jiménez L; Hernández-Pinto AM; Barrios V; Arilla-Ferreiro E
    Mol Cell Endocrinol; 2008 May; 286(1-2):104-11. PubMed ID: 18359553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease.
    Powers RE; Walker LC; DeSouza EB; Vale WW; Struble RG; Whitehouse PJ; Price DL
    Synapse; 1987; 1(5):405-10. PubMed ID: 3509803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and neuropeptide alterations in Alzheimer's disease.
    Bissette G; Nemeroff CB
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():33A-34A. PubMed ID: 1354039
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer's disease and morphologic alteration in non-demented elderly with numerous senile plaques.
    Benzing WC; Mufson EJ; Armstrong DM
    Brain Res; 1993 Oct; 625(1):125-38. PubMed ID: 8242391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor immunoreactive neurons persist throughout the brain in Alzheimer's disease.
    Kelley M; Kowall N
    Brain Res; 1989 Nov; 501(2):392-6. PubMed ID: 2819447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin in Alzheimer's disease and depression.
    Bissette G; Myers B
    Life Sci; 1992; 51(18):1389-410. PubMed ID: 1357521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: interactions between cholinergic functions and beta-amyloid.
    Yan Z; Feng J
    Curr Alzheimer Res; 2004 Nov; 1(4):241-8. PubMed ID: 15975053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.
    Bierer LM; Haroutunian V; Gabriel S; Knott PJ; Carlin LS; Purohit DP; Perl DP; Schmeidler J; Kanof P; Davis KL
    J Neurochem; 1995 Feb; 64(2):749-60. PubMed ID: 7830069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.